Pagina 2 - I migliori medici di Infusioni di vitamine - TOP-58medici

Dr. Seung‑Hyung Noh is a board-certified plastic and reconstructive surgeon. He has extensive experience in revision surgery for major aesthetic procedures. He is known for managing complex revision cases that call for sound judgment and precise technique.

He earned his medical degree from Hanyang University College of Medicine. He completed training in plastic and reconstructive surgery at Hanyang University Hospital. He also completed a clinical training program at Columbia University in New York.

His approach puts safety, balance, and natural results first. He avoids overtreatment and uses the least necessary intervention. He is a full member of major Korean plastic surgery societies, including KSPRS.

Anesthesiologist - Colombia 

Pain Medicine Specialist - Colombia ▪ Mg. in advanced pain management- Spain 

Certified in Stem Cells applications by ISSCA.  

Certified meditation teacher based on kindness and compassion- Spain 

Mg. in precision medicine - Spain 

Diploma in Orthomolecular Medicine. FUCS 2023 

International Online Workshop in Allogenic Cellular Based Products for Regenerative Medicine. International Society For Stem Cell Application ISSCA (10/28/2023) 

Certification of point of care regenerative medicine. International society for stem cell application ISSCA. Endorsed by Marmara University. (Nov 03-05 2023). Cancun, Mexico. Registration number 8229.

Member of International Society for Stem Cell Application (ISSCA) - Mexico (2023)

 Workshop on the use of Stem Cells and Ozone for degenerative disc disease (Regenerative Medicine in the Spine) - Lima - Peru. (April 2024) 

Functional and Integrative Doctor - Colombia, USA. (2018) 

Head of Teaching at the Puerto Vallarta Regional Hospital

2020-2023

Medical records manager at the Regional Hospital of Puerto Vallarta 2 months 2020

General practitioner in private medical office

2015-2022

Doctor in charge of weight control clinic

2013-2014

Medical assistant in dermatology clinic

2008-2013

Medical Assistant in Dermatological procedures.

 Medical Assistant in minimally invasive surgical procedures

 Operation of fractional laser machine - IPIXEL-ER and

facial rejuvenation with IPL.

 Experience in laser hair removal with Intense Pulsed Light and

radiofrequency

 Experience with ultrasonic cavitation

 Experience with ultraviolet (UV) light phototherapy machine for the

treatment of psoriasis and vitiligo.

 Experience assisting in Botox and Fillers procedures.

 Biomagnet certified by the Higher Institute of Biomagnetism

doctor ISAAC GOIZ DURAN

 Experience in clinical records

 Training in continuing education and professional development of teachers

Dr. Piyaphon On-phoon specializes in anti-aging and regenerative medicine. He also provides chelation therapy and immune therapy with high-dose vitamin and nutrition infusions.

He treats erectile dysfunction and offers hormone replacement therapy. He provides preventive care for noncommunicable diseases such as hypertension, atherosclerosis, diabetes, and dyslipidemia. He also treats skin diseases and offers aesthetic procedures using laser, HIFU, Thermage, Botox, and filler injections.

DR. Arzu Musaeva

Education: Azerbaijan Medical University.

Specialization: therapist

Working hours and days: weekdays 10:00-15:00.

Training and membership:

16.02-31.03.2000 thematic development of the cycle “Current issues of infectious diseases”.

02.01-15.02.2001 thematic cycle “Clinical pharmacotherapy of internal diseases”.

improvement.

01-30.12.2005 thematic improvement in the course “Chronic renal failure”.

22.11-27.12.2005 "Applied Homotoxicology" (56 hours) prof. Safihan Gasanov.

26-30.01.2006 "Applied Homotoxicology" (36 hours) Dr. Klaus Kuestermann (Baden-Baden,

Germany).

12-24.11.2006 "Applied Homotoxicology" (48 hours) Doctor of Technical Sciences Elena Nekrasova

23-28.04.2007 "Homeoisopathy" Dr. Burkhard Flechsig.

28.05-02.06.2007 "Sanum Therapy" Dr. Anita Krake (Germany).

13.12. 2008. “Microbiological Therapy” Doctor of Medical Sciences Michael Schreiber (Germany).

14-18.03.2008 "Module B" Dr. Marion Krasnitzer-Geyer, Dr. med. Siddhartha Popat (Baden-

Baden, Germany).

20-22.06.2008. "Acupuncture and Homeosiniatry" Dr. med. Siddhartha Popat (Baden-Baden,

Germany).

27-29.11.2009. "Introduction to Homeosiniatry" Dr. med. Joachim Bandlow.

02/16/2010. "Homotoxicology" Dr. Alta Smith.

05-09.11.2010. Course "Applied Homotoxicology" (36 hours). Dr. med. Burkhard Flechsig, Dr. med.

Joachim Bandlow.

21-22. 01.2011. "Introduction to Isopathy and Sanum Therapy". Med. Thomas Rau.

04.04.2011. "Microbiological Therapy" Dr. Kerstin Rasch, Dr. Volker Rusch.

10.20.2013. "Traditional medicine with biological medicine in diseases of the endocrinological and lymphatic systems"

"Sharing Methods" by Dr. Jurgen Frost.

07.04-02.05.2014 "Azerbaijan State Medical Institute named after A.Aliyev"

refresher course.

11/12/2014. "Inflammation: A New Concept" by Dr. Alta Smith.

10-11.04.2015. "Diabetes, Stress and Associated Diseases" Dr. med. Siddhartha Popat

(Baden-Baden, Germany).

12-16.05.2015. "Neurology, autoimmune diseases" Dr. of Medical Sciences Thomas Rau (Switzerland).

05/28/2015. "Basics of acid-base balance" "Hormones and health" Dr. med. Burkhard

Flechsig (Germany).

10.21.2015. "Fundamentals of Oncology" by Dr. Gerhard Reiss (Germany).

12/21/2015. "Mesotherapy" Dr. Alta Smith (Germany).

01-03.04.2016. Dr. "Allergy, Inflammation, Stress". Bert Hannosset (Germany).

05/28-29/2016 “Aesthetic Medicine” Dr. Tatiana Rivkina (Italy).

06/13-14/2016 “Fibromyalgia, Gout, Psoriasis” Dr. med. Gerhard Reis (Germany).

04-08.10.2016. "Mucosa Syndrome" Dr. Arturo Obirne (Colombia).

21.10. 2016. "Microbiological Therapy" by Dr. Uwe Peters (Germany).

31.10-01.11.2016. "Thyroid depletion syndrome" Dr. Gerhard Reiss (Germany).

10-11.11.2017. "Microbiological therapy – the basis of regulation" Dr. Uwe Peters (Germany).

12.2017. "Neurotherapy and Homotoxicology" Dr. med. Siddhartha Popat (Baden-Baden,

Germany).

2017. "Metabolic Syndrome" Dr. med. Annette Jaensch.

2017. "Healthy Aging, Proven Remedies in Integrative Medicine", Dr. Ralf Ottmaier

(Switzerland).

14-20.05.2018. "From segment to barrier, nutrition and inflammation, vitamin C and diabetes", doctor.

honey. Arturo Obirne (Colombia).

15-17.11.2018 "Elimination Therapy Methods, Success in Old Age" Dr. Marion Krasnitzer-Geyer

(Baden-Baden, Germany).

04.2018. "Bioregulatory treatment of chronic infections" Dr.rer.nat. Petra Grüning.

21-23.09.2018. "Possibilities of treating degenerative diseases using systemic bioregulatory medicine"

Doctor med. Siddhartha Popat (Baden-Baden, Germany).

01/25/2019. "Basics of mistletoe therapy with Helixor and its application in practice" Doctor of Medical Sciences Christfried

Preussler (Germany).

05/11/2019 “Mesotherapy” Dr. Nicoletta Frasca

05/14/2019. "Sanum Therapy for Liver Diseases" by Dr. Dieter Sonntag

06.04.2019. "Isn't fatigue the call of the liver?" Dr. Petra Grüning.

14-19.10.2019. "Bioregulatory treatment of dermatological diseases". med. Arturo Obirne

(Colombia).

Based on the results of successful treatment of trophic ulcers of various origins with biological preparations

Received the Hans-Heinrich Reckeweg Prize for clinical cases.

Examinations and treatment performed:

• Bioregulatory therapy of all therapeutic diseases.

• Atherosclerosis, stenosis, occlusion of peripheral arteries.

• Varicose veins, thrombophlebitis, thrombosis, lymphostasis of peripheral veins.

• Peripheral nerve neuropathy.

• Diabetic paw, osteoarthropathy, osteomyelitis.

• Detoxification and bioregulation of blood glucose at the cellular level. Diabetes mellitus

treatment and prevention of delayed complications in the lower extremities.

• Gangrenous pyoderma.

• Treatment of trophic ulcers.

Education:  Azerbaijan Medical University, Pediatrics, 2003-2009, Pediatrician  Ministry of Justice of the Republic of Azerbaijan, Intern, 2009-2010, Anesthesiologistreanimatologist (Intensive Therapy) Work experience:  Liv Bona Dea International Hospital, Emergency Physician June 2019 – present  International SOS (GIM) / BP AGT Caspian Sea "Shah Deniz Bravo" Project, Azerbaijan, Caspian Sea, Field doctor February 2017-November 2019  Azerbaijan National Anti-Doping Agency (AMADA), Azerbaijan, Baku, Doping Control Inspector June 2017  4th Islamic Solidarity Games, Azerbaijan, Baku, Medical consultant of Heydar Aliyev arena, May 2017  International SOS (GIM) / BP AGT Caspian Sea “Deepwater Gunashli” Project, Azerbaijan, Caspian Sea, Field Doctor January 2015 – January 2017  International SOS (GIM), Azerbaijan, Baku, site coordinator April 2014-December 2014  Doctor at the Central Neftchilar Hospital, Baku, Azerbaijan, Reanimation and Intensive Therapy Department (trial period) April-September 2012  Premium Assist Insurance Company, Azerbaijan, Baku, Chief Medical Expert (Night shift) AprilSeptember 2012  Medical intern at the Department of Anesthesiology and Intensive Therapy in various institutions under the Ministry of Justice of the Republic of Azerbaijan, Baku, Azerbaijan, August 2009- July 2010  Medi Club Clinic, Azerbaijan, Baku, Physician Assistant/Emergency paramedic August 2007 – July 2010 

La Dott.ssa Sirintip Jira-adsai è una rinomata specialista in Medicina Anti-Aging e Dermatologia, aiutando i pazienti a ottenere una pelle giovane e sana presso l'Asia Cosmetic Hospital.

• Specializzata in Medicina Anti-Aging, Dermatologia e Medicina Rigenerativa
• Anni di esperienza nel trattamento di vari problemi della pelle
• Esercita presso l'Asia Cosmetic Hospital a Bangkok
• Impegnata a rimanere aggiornata con gli ultimi progressi

12 anni di esperienza in medicina estetica con formazione specializzata nelle tecniche di infusione di vitamine. Il Dr. Ozcan dà priorità alla soddisfazione del paziente e ai trattamenti innovativi.

• Certificato dal Ministero della Salute turco in Mesoterapia e Ozonoterapia
• Ex primario con ruoli di leadership nella sicurezza e qualità ospedaliera
• Fluente in inglese e curdo per una migliore comunicazione con i pazienti

In his daily practice he pays special attention to:

Mohs micrographic surgery (a highly specialized surgical treatment for skin cancer).

Hair research and hair transplantation.

Removal of vascular lesions, pigmented lesions and tattoos using laser.

Skin rejuvenation (laser, peeling, botulinum toxin, fillers) and treatment of pigmented lesions.

Under his leadership, his team performs laser hair removal procedures and other cosmetic procedures.

In addition to other skin pathologies: acne, warts, psoriasis, surgical removal and periodic fight against moles and freckles, atopy, urticaria, etc.

Dr. Camps is President of the International Society of Dermatologic Surgery and founder of the European Society of Mohs Micrographic Surgery, and holds other positions in scientific organizations.

Medical and surgical dermatologist at the Teknon Medical Center

Doctor of Medicine and Surgery, University of Barcelona.

Specialist in medical and surgical dermatology. Doctoral dissertation: "Mohs micrographic surgery".

Expert in dermatological surgery aimed at treating skin tumors.

Head of the Dermatology Service at the General Hospital of Catalonia.

Medical Director of Dermals, S.L. (Teknon Medical Center) since its foundation.

Founder of the European Society of Mohs Micrographic Surgery.

He was President of the International Society of Dermatologic Surgery (ISDS).

Vice President of the Spanish Skin Cancer Association (ASECUT).

Founder of the Spanish Laser Group, belonging to the Spanish Academy of Dermatology (AED).

Founder and Vice President of the Spanish Society of Hair Transplantology.

Active member of a number of national and international dermatological societies.

Organizer, co-author and speaker of numerous courses on dermatology and dermatologic surgery at national and international level.

In 1981 he graduated from the Faculty of Medicine and Surgery of the University of Barcelona.

Specialist in medical-surgical dermatology and venereology MIR at the Hospital del Sagrado Corazon in Barcelona in 1987.

After completing his specialty, he worked as a doctor at the Hospital del Sagrado Corazón in Barcelona until 1993, where he gained experience in dermatological surgery and laser therapy.

In 1994, he founded the Dermatology Department of the Teknon Medical Center, where he is currently a prominent collaborator and Medical Director. Over the years, he has created and consolidated a team of professionals with a wide range of specialties in clinical dermatology, aesthetics, oncology and laser therapy. In addition to coordinating training groups for dermatology doctors.

In 2014, he founded the DermAndTek clinic in Andorra with the aim of providing comprehensive services in clinical and aesthetic dermatology using the latest technologies in laser therapy, prevention and treatment of skin cancer.

The Dr. López Gil Dermatology Clinic is a team of dermatologists from the Quiróns Teknon Hospital in Barcelona, specialising in various areas of clinical dermatology, aesthetic dermatology, laser treatments, hair treatments and the latest medical technologies.

Their specializations:

- Clinical dermatology

- Aesthetic dermatology

- Oncological dermatology

- Hair loss

- Laser therapy

- Excessive sweating and hyperhidrosis

- Venereal diseases

Education and Specialization

• 2004/2010: Fırat University Faculty of Medicine
• 2012/2017: Uludağ University Faculty of Medicine – Specialization

Experience

• 2017/2021: Ankara Training and Research Hospital
• 2021/2023: Kilis State Hospital
• 2023/2024: Private Gaziantep Emek Hospital

Professional Memberships

• Aesthetic and Cosmetic Dermatology Society (Estetik ve Kozmetik Dermatoloji Derneği)
• Turkish Dermatology Society (Türk Dermatoloji Derneği)
• Turkish Medical Association (Türk Tabipler Birliği)

Makbule DÜNDAR, M.D.

Dermatology

Areas of Expertise and Interest

• General Dermatology
• Venereal Diseases
• Cosmetic Dermatology
• Laser Treatments
• Dermoscopy
• Non-surgical Aesthetic Procedures (Peeling, Fillers, Botulinum Toxin, etc.)

Education and Career

• 1989 – 1995 Istanbul University, Istanbul Faculty of Medicine – M.D. Degree
• 1996 – 1999 Haseki State Hospital – Dermatology Residency Training
• 1999 – 2003 Fizikom Aesthetic and Laser Center – Specialist in Dermatology
• 2003 – 2006 TBV Hizmet Hospital – Specialist in Dermatology
• 2006 – 2008 Medical Park Bahçelievler Hospital – Specialist in Dermatology
• 2008 – 2014 Private Istanbul Medipol Hospital – Specialist in Dermatology
• 2014 – 2017 Memorial Wellness – Specialist in Dermatology
• 2017 – 2024 Saltat Clinic, Göztepe Branch – Specialist in Dermatology
• 2024 – Present Medipol Acıbadem District Hospital – Specialist in Dermatology, Head of Aesthetic Medicine Department

Career

Born in 1960 in Turkey, Dr. Makbule Dündar graduated from Istanbul University Faculty of Medicine in 1995 and completed her residency in Dermatology at Haseki State Hospital in 1999. Throughout her career spanning over two decades, she has worked in prestigious institutions and clinics, focusing on both clinical dermatology and aesthetic procedures. Her interests include laser therapies, dermoscopy, and minimally invasive cosmetic applications. She has participated in numerous international congresses, workshops, and hands-on trainings.

She currently serves as the Responsible Physician of the Aesthetic Medicine Department at Medipol Acıbadem District Hospital, where she combines her medical expertise with cosmetic dermatology practice.

Publications

• Congenital Cutis Marmorata Telangiectatica: A Case Report – Çiftçi M., Erdoğan F., Dündar M. – Haydarpaşa Numune Medical Journal, 2012
• A Case of Lichen Planus Pemphigoides – Dündar M., Derviş E., et al. – Turkiye Klinikleri Dermatology, 2000
• The Role of Dermoscopy in Diagnosing Pigmented Lesions – Derviş E., Dündar M., et al. – Haseki Medical Bulletin, 2000
• The Importance of Dermoscopy in Pigmented Lesions – Specialization Thesis, 1999

Certifications and Awards

• Numerous practical training programs in botulinum toxin, dermal fillers, peeling, and aesthetic lasers
• Participation in multiple national and international dermatology congresses and workshops
• Recipient of various hands-on training certificates in aesthetic dermatology, dermatosurgery, and team management in healthcare

Professional Affiliations and Memberships

• Istanbul Medical Chamber
• Turkish Society for Dermatology and Venereology
• Turkish Dermatology Association
• European Academy of Dermatology and Venereology (EADV)

Dr. Erkan Davarci is a dermatologist at Medical Park Antalya Hospital Complex. He earned his MD from Ankara University Faculty of Medicine. He completed his dermatology residency at Ankara Dışkapı Yıldırım Beyazıt Training and Research Hospital. He then fulfilled his compulsory service at the Ministry of Health’s Kelkit State Hospital.

Clinical practice: general dermatology, cosmetic dermatology, laser and energy-based skin treatments, mole and skin lesion care, botulinum toxin and dermal fillers, skin rejuvenation.

Memberships: Aesthetic and Cosmetic Dermatology Society, Turkish Dermatology Society, Turkish Medical Association.

I was born in Naples, born in 1981, and I have the best job in the world. Imagine waking up every morning and knowing that on that day you will make someone's dream come true: you will change a man's life forever, you will give birth to a new woman, you will help a girl achieve happiness, a boy gain self-confidence. I am Silvio Ascione, specialist in Plastic, Reconstructive and Aesthetic Surgery. Son of art, from my father, a great man and great plastic surgeon, I learned the complex and enchanting magic of aesthetic plastic surgery. Nourished by art and medical knowledge, I grew up in operating theatres, always behind my father's back who, like the best of masters, passed on to me, a young disciple, the passion for a profession in which art combines to science to create masterpieces. Graduated in Medicine and Surgery in 2005 from the Second University of Naples, qualified in the first session of 2006 and specialized in Plastic, Reconstructive and Aesthetic Surgery at the School of Specialization of the Second University of Naples directed by Prof. Francesco D'Andrea, I am enrolled in the 'Order of Surgeons of Benevento and I obtained a Master's degree in Oncoplastic Surgery and integrated treatments at the University of Genoa.

My experience in the surgical room, however, began much earlier, and it was an intense, very hard journey, characterized by total dedication, constant updating, continuous training: initially internal at the Department of Plastic, Reconstructive and Aesthetic Surgery of the S.U.N., I frequented then the Department of Reconstructive and Aesthetic Plastic Surgery of the Mediterranean Clinic of Naples affiliated with the “Tor Vergata” University of Rome, the A.O.R.N. Major Burns Center Department, directed by Prof. Roberto D'Alessio, the Trauma Center Department of Prof. Antonio Martin.

I regularly participate in all the main national and international Plastic Surgery conferences to stay constantly updated on the technological innovations offered by the market, the cutting-edge products and instruments to be used for my treatments, the new research and the most recent studies in the field of plastic and aesthetic surgery.

I studied and carried out in-depth internships at universities and hospital centers in Spain, France and North America, gaining extraordinary experience on the most advanced surgical techniques, in particular on facial and breast rejuvenation.

​

MY MISSION

My innate passion for surgery, my attention to the care of the image and the harmony of forms, my obsessive precision and attention to detail, my unstoppable research and updating activity, my decades of experience in the most varied spheres of plastic and aesthetic surgery, working side by side with my specialized team, allow me today to boast a curriculum full of successes and satisfactions and to be able to offer my patients a detailed and scrupulous visit, a precise diagnosis, a treatment plan personalized and efficient intervention, agreed on the basis of the patient's needs and desires, highly effective personal techniques and tools to eliminate all types of blemishes, signs of aging or congenital imperfections, through increasingly less invasive interventions and with increasingly natural results.

​

Experience, professionalism, harmony, naturalness: these are the four key points on which I build a relationship that is first human, then professional, with my patient. The choice of plastic or aesthetic surgery does not only involve the decision to undertake a path of external change. For this reason I dedicate myself with dedication and attention to listening to the discomforts and wishes of each of my patients, so that we can plan together the most appropriate intervention for their needs and to achieve the expected result and to accompany them step by step towards a path of external and internal rebirth

PROFESSIONAL EXPERIENCE

2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine

2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine

06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine

10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship

2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship

2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist

2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.

EDUCATION

2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.

2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

INTERNATIONAL CLINICAL TRIALS:

1. Astefania - ROCHE

• Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
• Role: Subinvestigator

2. PFİZER

• Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
• Role: Subinvestigator

3. RECITE - AMGEN

• Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
• Role: Subinvestigator

4. NAVIGATE - BAYER

• Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
• Role: Subinvestigator

5. RUBY - Tesaro (PRA)

• Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
• Role: Subinvestigator

6. ENGOT-ov43/GOG-3036 - MSD

• Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
• Role: Subinvestigator

7. ASTRA ZENECA

• Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
• Role: Subinvestigator

8. ROSY-O - ASTRA ZENECA

• Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
• Role: Subinvestigator
•  

INTERNATIONAL PUBLICATIONS

I. Published journal articles indexed by SCI, SSCI, and AHCI

Weekly Paclitaxel in Classic Kaposi Sarcoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
• Journal: Medicine, 102(5)

Carboplatin Desensitization in Ovarian Carcinoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
• Journal: Medicine, 101(45), e31726

High-Dose Chemotherapy for Ewing’s Sarcoma

• Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
• Journal: Medicine, 101(49), e32213

Multidrug Refractory TFE3(+) Renal Cell Carcinoma

• Authors: Paksoy, Nail, et al.
• Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

Crizotinib Efficacy in NSCLC with MET Alterations

• Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
• Journal: Medicine, 101(50), e32368

Clinicopathological Features in ALK Mutant NSCLC

• Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
• Journal: Medicine, 101(34)

PSMA-Based Tumor Burden in Prostate Cancer

• Authors: HAS SIMSEK, Duygu, et al.
• Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

Atezolizumab in Metastatic Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: European Urology Focus, 2021, 7.5: 1061-1066

Pulmonary Sarcomatoid Carcinoma

• Authors: FERHATOGLU, Ferhat, et al.
• Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

Atezolizumab with Chemotherapy in Small Cell Lung Cancer

• Authors: GÜRBÜZ, Mustafa, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

• Authors: AY, Seval, et al.
• Journal: Journal of Chemotherapy, 2022, 1-7

Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

• Authors: CIL, Ibrahim, et al.
• Journal: Tumori Journal, 2022, 108.1: 19-25

Real-Life Efficacy of Osimertinib in Advanced NSCLC

• Authors: HIZAL, Mutlu, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

ALK-Positive Cells Percentage and Alectinib Efficacy

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
• Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

Real-World Data on Alectinib in ALK-Positive NSCLC

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
• Journal: Future Oncology, 18(23), 2573-2582

Prognostic Factors in Metastatic RCC with T790M Mutation

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

• Authors: DEMIR, Semra, et al.
• Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

• Authors: ÖZDEMIR, Seçil Kepil, et al.
• Journal: Allergy, 2019, 74.6: 1187-1190

Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

• Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
• Journal: The Oncologist, oyad257

Subsequent Treatments in Hormone-Positive Breast Cancer Progression

• Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
• Journal: BMC cancer, 23(1), 192

Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
• Journal: Scientific Reports, 13(1), 8779

Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
• Journal: Journal of Cancer Research and Clinical Oncology, 1-9

Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

• Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
• Journal: European Journal of Breast Health, 19(2), 128

Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

• Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
• Journal: Future Oncology, 19(10), 727-736

Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

• Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
• Journal: [Not specified]

Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

• Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
• Journal: Medicine, 102(39), e35383

Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

• Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
• Journal: Medicine, 102(41), e35245

Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

Thesis:

Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

• Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

• Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

• Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

Efficacy of temozolomide in pretreated patients with metastatic sarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

• Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

• Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

• Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

• Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

• Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

Dr. Ayse Callioglu is a dermatologist. She focuses on dermal fillers, facial lifting, rhinoplasty (nose aesthetics), chemical peels, acne treatment, and Botox.

Education: Ege University Faculty of Medicine. Akdeniz University Faculty of Medicine.

Clinical experience includes Private Anadolu Hospital and Medstar Hospital. She has also worked at Lara Yaşam Hospital and Medical Park Antalya.

Accreditations/Memberships: Turkish Society of Dermatology and Mediterranean Society of Dermatology. International Society of Cosmetic Dermatology and European Academy of Dermatology and Venereology.

Chief physician, osteopathic therapist

Respiratory diseases (outpatient treatment of chronic obstructive pulmonary disease and bronchial asthma)

Allergic diseases

Gastrointestinal diseases

SPECIALITY:

Osteopathic therapist

Training and membership:

1991-1998 Azerbaijan Medical University, Faculty of Medicine

Internship in therapy in 1998-1999.

From 2004 to 2018 in the areas of application of Integrative Medicine - acupuncture, homeosiniatry,

biopuncture, neurotherapy, hirudotherapy, segmental therapy and other improvements

completed the courses.

2011-2012 – specialization “Bioresonance diagnostics and therapy” at MPEI.

In 2014-2018, he received a degree in osteopathy at the St. Petersburg Institute of Osteopathy.

2016 in Istanbul Çapa Hospital, 2018 in Ankara GATA Keçiören Hospital.

participated in experimental practice.

Participated in the 1st and 2nd Microbiome Congresses in Turkey in 2021-2022.

COVID19 Lung as speaker at Family Medicine Summit 2021 in Turkey

He spoke about the complications.

foreign specialists in Germany, various cities of Turkey and Azerbaijan

participated in many conferences

General Practitioner/ Medical Director
certified by American Academy of Anti-Aging Medicine

A credentialed physician, general practitioner, MD has gained valuable

diverse experience and a special interest in Aesthetic Medicine. Dr. Farshad is a

certified member of the American Academy of Anti-Aging Medicine (A4M),

certified in advanced injectables and laser therapy  by the National Council on Laser Certification (NCLC) USA.
 

Dr. Farshad comes from a family of medical practitioners. In 1998, he graduated from Shiraz (Pahlavi) University of Medical Sciences. Since then, having great career achievements in Family Medicine across Canada and UAE, he pursued gaining knowledge and practice in aesthetics. Following his passion he performs with a holistic and professional approach to - as he calls it - “Feel-Good procedures” to turn back the hands of time and help his patients, to meet their desire in looking young, fresh and rejuvenated.

Doctor Farshad is mastered in a myriad of aesthetic procedures including Botox and Dermal filler injections, non-surgical facelift advanced methods and various laser Treatments and Laser Therapy. His vast international and multicultural experience allows him the understanding and balance of East and West when caring and treating patients from all backgrounds and ethnicities.

Besides extensive experience, his obsession with details and unrivalled precision for creating the most outstanding natural results has made him to be able to combine the vision of Art and Aesthetics with the most advanced medical treatments to enhance the natural beauty of each individual.
 

Areas of activity: • Research of pathology in gerontological age group (elderly) patients • Clinical nutrition (enteral and parenteral nutrition) • Diabetes mellitus, metabolic syndrome, osteoporosis, thyroid diseases • Arterial hypertension • High body temperature of unknown genesis (fever) • Diseases of the musculoskeletal system, rheumatological diseases • Diseases of the gastrointestinal tract, liver • Disorders of water and electrolyte metabolism, kidney diseases Education: • Higher education - Azerbaijan Medical University, Faculty of General Medicine and Prevention, 2008-2014 • Specialization – Istanbul University, Istanbul Faculty of Medicine, Department of Internal Medicine Work experience: • Baku State Hospital No. 3, resident physician nephrologist. 2014-2016 • Istanbul Private Bahcelievler Memorial Hospital, specialist in internal medicine. 2021-2022 Research work: (dissertation / defense) • Clinical and laboratory features of patients with acute interstitial nephritis diagnosed during kidney biopsy, factors influencing the etiology and response to treatment. Istanbul University, Istanbul Faculty of Medicine, Department of Nephrology, 2021 Publications:(2) •P343Efficacy of adalimumab mild-to-moderate inflammatory bowel disease: Real-life data from a single-centre experience in the long-term period. January 2020 Journal of Crohns and Colitis DOI: 10.1093/ecco-jcc/jjz203.472 •Concurrent myelomatous pleural effusion and extramedullary mediastinalinvolvement as a relapse manifestation of multiple myeloma. Abstract of the IXth International Eurasian Hematology OncologyCongress17–20October2018Istanbul,Turkey(Concomitant myelomatous pleurisy and extramedullary mediastinal lesion as a recurrent manifestation of multiple myeloma. Abstracts of the IX International Eurasian Oncohematology Congress17–20October2018Istanbul,Türkiye) Memberships in scientific organizations: •Turkish Medical Association

ACADEMIC EXPERIENCE 

2010 Degree of Doctor in Medicine 

2010 Bachelor in Nutritional Sciences 

2018 Member of AMPTI (Mexican Association of Professionals in Intravenous Therapy)

2020 Master Degree in Regenerative Medicine 

2023 Certification of RCG, the more important Medical Community of Regenerative Medicine of Mexico 

PROFESSIONAL EXPERIENCE 

2010 - 2013 Clinical Nutritionist in private hospitals and clinics

2013 - 2015 Nutritionist in the Medical Spa of Papaya Playa Project Hotel in Tulum 

2015 - 2016 Doctor in the Red Cross

2016 - 2018 Medical consultations and Vitamin  IV Drip in the best hotels of Tulum: Be Tulum, Nomade, Casa Malca, Azulik, Papaya Playa Project 

2017 - 2019 Specialst in Healing Wound Clinic with PRP and Stem Cells  

2015 - 2019 Vitamin IV Drip in hotels and private houses

2020 - 2024 Specialist in Regenerative Medicine - Stem Cells